[1]
Parul Srivastava et al. 2022. BEYOND BLOOD SUGAR CONTROL: A COMPREHENSIVE REVIEW OF DPP-4 INHIBITORS AND THEIR EXPANDING LANDSCAPE. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Nov. 2022), 1273–1303. DOI:https://doi.org/10.53555/jptcp.v29i04.4372.